CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Potential role of fecal microbiota in patients with constipation

Open access
Tian, Yan, Zuo, Luo, Guo, Qin, Li, Jun, Hu, Zhangyong, Zhao, Kui, Li, Can, Li, Xiaohui, Zhou, Jinggang, Zhou, Yan, Li, Xiao-an · 2020 · Therapeutic Advances in Gastroenterology

Abstract

Background: We evaluated the safety and efficacy of fecal microbiota transplantation (FMT) for chronic functional constipation (CFC) ineffectively treated by conventional constipation medication. Methods: Thirty-four patients with CFC underwent FMT treatment (three rounds, via gastroscopy). Clinical scales, including the Wexner constipation score as the main index of efficiency, were completed at baseline; after each treatment, and at 2 and 3 months of follow up. Secondary evaluation indices included the self-assessment of constipation symptoms, patient assessment constipation quality-of-life questionnaire, Bristol stool form scale, and Zung’s self-rating depression and anxiety scales. Gastrointestinal motility, motilin, gastrin, nitric oxide (NO), and 5-hydroxytryptamine (5-HT) were assessed before and after treatment. Intestinal flora changes were assessed by 16S ribosomal ribonucleic acid (rRNA) sequencing. Results: There were no serious adverse reactions. The clinical cure rate was 73.5% (25/34), clinical remission rate was 14.7% (5/34), and the inefficiency rate was 11.8% (4/34). Clinical scale data indicated that the FMT treatment was effective. Furthermore, FMT treatment promoted intestinal peristalsis, increased gastrointestinal motility, and increased serum NO and 5-HT levels. The 16S rRNA sequencing data indicated that high abundances of Bacteroides, Klebsiella, Megamonas, Erysipelotrichaceae and Epulopiscium may be the cause of constipation, and high abundances of Prevotella, Acidaminococcus and Butyricimonas may be the main factors in curing constipation. Conclusion: Treatment with FMT regulates the intestinal microflora and changes the abundance of CFC-associated bacterial flora to improve constipation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1756284820968423

Cites

Statistics

Figures

Figure 1. The clinical evaluation indices used to comprehensively evaluate the clinical efficacy of FMT. (a) Wexner constipation score (WCS); (b) self-assessment of constipation symptoms (SACS); (c) patient assessment constipation quality-of-life questionnaire (PAC-QOL); (d) Bristol stool form scale (BSFS); (e) Zung’s self-rating depression scale (SDS); and (f) Zung’s self-rating anxiety scale (SAS). FMT, fecal microbiota transplantation.
Figure 1. The clinical evaluation indices used to comprehensively evaluate the clinical efficacy of FMT. (a) Wexner constipation score (WCS); (b) self-assessment of constipation symptoms (SACS); (c) patient assessment constipation quality-of-life questionnaire (PAC-QOL); (d) Bristol stool form scale (BSFS); (e) Zung’s self-rating depression scale (SDS); and (f) Zung’s self-rating anxiety scale (SAS). FMT, fecal microbiota transplantation.CC BY-NC · PubMed Central
Figure 2. Changes in the expression of NO, 5-HT, motilin, and gastrin with FMT treatment. (a) Serum NO and 5-HT levels before and after FMT treatment (mean ± SD) and (b) serum motilin and gastrin levels before and after FMT treatment (mean ± SD). FMT, fecal microbiota transplantation; NO, nitric oxide; 5-HT, 5-hydroxytryptamine; SD, standard deviation.
Figure 2. Changes in the expression of NO, 5-HT, motilin, and gastrin with FMT treatment. (a) Serum NO and 5-HT levels before and after FMT treatment (mean ± SD) and (b) serum motilin and gastrin levels before and after FMT treatment (mean ± SD). FMT, fecal microbiota transplantation; NO, nitric oxide; 5-HT, 5-hydroxytryptamine; SD, standard deviation.CC BY-NC · PubMed Central
Figure 3. Venn diagrams of the shared and unique operational taxonomic units (OTUs) among all groups. Each ellipse in the figure represents a sample set. The number in the overlap region represents the number of OTUs shared between the sample sets. The number without overlap indicates the number of OTUs unique to the sample set. The lower histogram shows the total number within each sample set.
Figure 3. Venn diagrams of the shared and unique operational taxonomic units (OTUs) among all groups. Each ellipse in the figure represents a sample set. The number in the overlap region represents the number of OTUs shared between the sample sets. The number without overlap indicates the number of OTUs unique to the sample set. The lower histogram shows the total number within each sample set.CC BY-NC · PubMed Central
Figure 4. Relative abundances of fecal microbiota at phylum and genus level in patients with chronic functional constipation before and after treatment. Different colors represent different bacterial species. (a) The 10 most abundant species at the phylum level. The abscissa indicates the sample name, and the vertical bar represents a sample; (b) the 20 most abundant species at the genus level. The abscissa indicates the sample name, and the vertical bar represents a sample; (c) the 10 most abundant species at the phylum level. The abscissa represents the group, and the vertical bar represents a group; and (d) the 20 most abundant species at the genus level. The abscissa represents the group, and the vertical bar represents a group.
Figure 4. Relative abundances of fecal microbiota at phylum and genus level in patients with chronic functional constipation before and after treatment. Different colors represent different bacterial species. (a) The 10 most abundant species at the phylum level. The abscissa indicates the sample name, and the vertical bar represents a sample; (b) the 20 most abundant species at the genus level. The abscissa indicates the sample name, and the vertical bar represents a sample; (c) the 10 most abundant species at the phylum level. The abscissa represents the group, and the vertical bar represents a group; and (d) the 20 most abundant species at the genus level. The abscissa represents the group, and the vertical bar represents a group.CC BY-NC · PubMed Central
Figure 5. Diagram of the linear discriminant analysis (LDA) score. The LDA score chart is shown for species with an LDA score greater than 2, which can be used as a biomarker for each group.
Figure 5. Diagram of the linear discriminant analysis (LDA) score. The LDA score chart is shown for species with an LDA score greater than 2, which can be used as a biomarker for each group.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 22 · Cited by 68

Research works printed but not linked: 3

  1. Ulusoy E, 2016, Minerva Pediatr
  2. Harucha AE, 2020, Gastroenterology, 158, e3
  3. Merkel IS, 1993, Am J Gastroenterol, 88, 1854

Metadata

Authors
Tian, Y., Zuo, L., Guo, Q., Li, J., Hu, Z., Zhao, K., Li, C., Li, X., Zhou, J., Zhou, Y., & Li, X.-A.
Affiliations
Chengdu Medical College (CN)
Corresponding author
Li, Xiao-an
Venue
Therapeutic Advances in Gastroenterology
Published
2020-01
Volume
13
Pages
1756284820968423-1756284820968423
ISSN
  • 1756-283X (ISSN-L)
  • 1756-2848
OpenAlex
W3094870394
Cited by
68
References
22
Citations by year
2026: 6 · 2025: 16 · 2024: 13 · 2023: 17 · 2022: 12 · 2021: 4
FWCI
7.16
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Gastroenterology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
the First Affiliated Hospital of Chengdu Medical College (CYFY2017XH01, CYFY2017XH03, CYFY2017XH04, CYFY2019GLPXH01, CYFY2019GLPXH02)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
Keywords
fecal microbiota transplantation, chronic functional constipation, gut microbiota, gastrointestinal motility, nitric oxide, serotonin, Wexner score, 16S rRNA gene sequencing, Bacteroides, Prevotella, treatment efficacy and safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potential role of fecal microbiota in patients with constipation. https://app.cochat.ai/papers/10.1177/1756284820968423
The paper
Tian, Y., Zuo, L., Guo, Q., Li, J., Hu, Z., Zhao, K., Li, C., Li, X., Zhou, J., Zhou, Y., & Li, X.-A. (2020). Potential role of fecal microbiota in patients with constipation. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756284820968423

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.